Related Experiment Video
Updated: Jun 20, 2026
Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
Published on: October 23, 2019
Genome-wide study of Pseudomonas aeruginosa outer membrane protein immunogenicity using self-assembling protein
Wagner R Montor1, Jin Huang, Yanhui Hu
1Harvard Institute of Proteomics, Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, and Boston Children's Hospital, Boston, MA 02115, USA.
Abstract:
Pseudomonas aeruginosa is responsible for potentially life-threatening infections in individuals with compromised defense mechanisms and those with cystic fibrosis. P. aeruginosa infection is notable for the appearance of a humoral response to some known antigens, such as flagellin C, elastase, alkaline protease, and others. Although a number of immunogenic proteins are known, no effective vaccine has been approved yet. Here, we report a comprehensive study of all 262 outer membrane and exported P. aeruginosa PAO1 proteins by a modified protein microarray methodology called the nucleic acid-programmable protein array. From this study, it was possible to identify 12 proteins that trigger an adaptive immune response in cystic fibrosis and acutely infected patients, providing valuable information about which bacterial proteins are actually recognized by the immune system in vivo during the natural course of infection. The differential detections of these proteins in patients and controls proved to be statistically significant (P<0.01). The study provides a list of potential candidates for the improvement of serological diagnostics and the development of vaccines.
Insights
Researchers identified 12 outer membrane and exported proteins from Pseudomonas aeruginosa that trigger immune responses in cystic fibrosis patients. This finding aids in developing new diagnostics and vaccines for P. aeruginosa infections.
Area of Science:
- Microbiology
- Immunology
- Infectious Diseases
Background:
- Pseudomonas aeruginosa causes severe infections, particularly in immunocompromised individuals and cystic fibrosis patients.
- While immune responses to P. aeruginosa antigens are known, effective vaccines are lacking.
- Identifying key immunogenic proteins is crucial for vaccine and diagnostic development.
Purpose of the Study:
- To comprehensively screen P. aeruginosa outer membrane and exported proteins for immunogenicity.
- To identify bacterial proteins recognized by the immune system during natural infection in patients.
- To discover potential targets for improved serological diagnostics and vaccine development.
Main Methods:
- Utilized a nucleic acid-programmable protein array to analyze 262 P. aeruginosa PAO1 outer membrane and exported proteins.
- Screened for proteins eliciting an adaptive immune response in patient cohorts.
- Performed statistical analysis to determine significant differences between patient and control groups.
Main Results:
- Identified 12 P. aeruginosa proteins that significantly trigger adaptive immune responses in cystic fibrosis and acutely infected patients (P<0.01).
- These proteins are recognized by the host immune system in vivo during natural infection.
- Demonstrated statistically significant differential detection of these proteins in patients versus controls.
Conclusions:
- The 12 identified proteins are promising candidates for P. aeruginosa serological diagnostics.
- These proteins represent potential targets for the development of novel P. aeruginosa vaccines.
- This study provides valuable insights into the in vivo immune recognition of P. aeruginosa during infection.
